제노레이

122310KOSDAQ의료용 기기 제조업

48.0 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment20.0 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but PER raises overvaluation concerns. Plunged 25.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Genoray develops, manufactures, and sells X-ray imaging diagnostic equipment for medical and dental environments. The company operates both medical (C-arm, Mammography) and dental (Panorama, CT, Portable) segments, uniquely being the only South Korean firm offering both. The medical segment focuses on real-time imaging during surgeries and breast disease diagnosis, while the dental segment provides high-resolution 3D imaging technology for dental treatments and implant surgery.

Number of Employees

358people

Average Salary

56.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

57.30Industry Average 21.510.0Point

2.7x industry avg (risky)

PBR

0.61Industry Average 1.387.0Point

Half of industry avg (excellent)

ROE

0.74Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

8.99Industry Average 11.654.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼76.4% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.8% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 80

Positive
휴이노, IPO·글로벌 확장 앞두고 이사회 개편
휴이노의 경영진 및 이사회 개편은 IPO와 글로벌 확장 전략 강화로 이어져 긍정적인 시장 반응을 예상.
Positive
제노레이, C-arm·맘모그래피 등 3개 분야 국내 점유율 1위 기록
제노레이가 주요 의료 영상 장비 분야에서 국내 시장 점유율 1위를 달성하며 긍정적인 성과를 보였습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 3,495Won52-week high 5,90052-week low 3,495

1-month return0.0Point

1m -25.32% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-05-27
Neutral분기보고서 (2026.03)2026-05-15